$TCBX Cashflow Statement | Understand Stock

$TCBX

$40.17 +$0.05 (0.12%) Close

$TCBX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses
Changes in deferred tax, net
Share based compensation expense
Loss (gain) on sale of investment securities available-for-sale
Gain on sale of SBA loans
(Write-up) write-down of other real estate owned
Loss on sale of other real estate owned
Write-down of fixed assets
Accretion of discount on securities, net
Accretion of fees on derivative instruments
Accretion of gain on terminated cash flow hedges
Accretion of SBA Paycheck Protection Program fees
Accretion of loan fees
Amortization of subordinated debt origination costs
Depreciation, amortization and accretion
Depreciation and amortization
Earnings on bank-owned life insurance
Proceeds from sale of loans held for sale
Net change in operating leases
Net change in fair value hedge assets and liabilities
Net change in derivative assets and liabilities
Changes in operating assets and liabilities:
Accrued interest receivable and other assets
Accrued interest payable and other liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Net decrease (increase) in interest bearing deposits in other banks
Net (purchase) sale of non-marketable equity securities
Investment securities available-for-sale activity:
Purchases
Sales
Maturities, calls and principal paydowns
Purchases of investment securities held-to-maturity
Proceeds from termination of derivative instruments
Net originations on loans held for investment
Proceeds from disposal of fixed assets
Net additions to bank premises and equipment
Proceeds from sales of foreclosed assets
Purchase of bank owned life insurance
Net cash used in investing activities

Cash flows from financing activities:
Net increase in deposits
Net repayment of FHLB Advances
Repayment of notes payable
Net proceeds from subordinated debt issuance
Net repayment of subordinated notes payable - related party
Net proceeds from (repayment of) line of credit - senior debt
Net proceeds from issuance of preferred stock
2022 Private Placement Offering
Total net proceeds from issuance of preferred stock
Registration costs for securities issued in private placement
Proceeds from stock warrants exercised
Forfeiture of restricted stock grants withheld to satisfy tax obligations
Proceeds from stock options exercised
Dividends paid on Series A preferred stock
Net redemption of treasury stock
Net cash provided by financing activities

Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid for income taxes
Cash paid for federal income taxes
Cash paid for state income taxes, net of refunds
Supplemental Disclosure of Noncash Investing and Financing Activities:
Loans transferred to other real estate owned, net
Right of use lease assets obtained in exchange for operating lease liabilities
Net increase in fair value of ESOP-owned shares
Terminated ESOP put option
Reclassification of investment securities from held-to-maturity to available-for-sale

Comments